| 产品名称: | NCI-H1734 H-1734, H1734 |
|---|---|
| 商品货号: | TS211330 |
| Organism: | Homo sapiens, human |
| Tissue: | lung |
| Product Format: | frozen |
| Morphology: | epithelial |
| Culture Properties: | adherent |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease: | adenocarcinoma; non-small cell lung cancer |
| Age: | 56 years |
| Gender: | female |
| Storage Conditions: | liquid nitrogen vapor phase |
| Derivation: | The line was established in September 1987. |
| Clinical Data: | female The tissue donor was a non-smoker. |
| Comments: | The tissue donor was a non-smoker. |
| Complete Growth Medium: | The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
|
| Subculturing: | Volumes are given for a 75 cm2 flask. Increase or decrease the amount of dissociation medium needed proportionally for culture vessels of other sizes.
Subcultivation Ratio: A subcultivation ratio of 1:4 to 1:6 is recommended |
| Cryopreservation: | Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase |
| Culture Conditions: | Atmosphere: air, 95%; carbon dioxide (CO2), 5% Temperature: 37°C |
| STR Profile: | Amelogenin: X CSF1PO: 13 D13S317: 11,12 D16S539: 12 D5S818: 10 D7S820: 10,11 THO1: 7,9.3 TPOX: 11 vWA: 17 |
| Name of Depositor: | AF Gazdar, JD Minna |
| Deposited As: | Homo sapiens |
| Year of Origin: | September, 1987 |
| References: | NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996. Sordella R, et al. Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305: 1163-1167, 2004. PubMed: 15284455 |